p97 Inhibition Synergistically Enhances Hypomethylating Therapy through Targeting of PLK1 in Acute Myeloid Leukemia.

Nawrocki ST, Wang N, Espitia CM, Wu H, Villa Celi C, Olea J, Zarand P, Dadrastoussi H, Matta H, Sureshkumar S, Gamble ME, Hakim NL, Drum D, Angeles J, Wu K, Zhong JF, Chen X, Duong A, Carew JS, Kelly KR

Open source

DOI
10.1158/2767-9764.crc-26-0035
Published
2026 Jun 1
Container
Cancer research communications
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1158/2767-9764.crc-26-0035,
  title = {p97 Inhibition Synergistically Enhances Hypomethylating Therapy through Targeting of PLK1 in Acute Myeloid Leukemia.},
  author = {Nawrocki ST and Wang N and Espitia CM and Wu H and Villa Celi C and Olea J and Zarand P and Dadrastoussi H and Matta H and Sureshkumar S and Gamble ME and Hakim NL and Drum D and Angeles J and Wu K and Zhong JF and Chen X and Duong A and Carew JS and Kelly KR},
  year = {2026},
  journal = {Cancer research communications},
  doi = {10.1158/2767-9764.crc-26-0035},
  url = {https://doi.org/10.1158/2767-9764.crc-26-0035}
}

RIS

TY  - JOUR
TI  - p97 Inhibition Synergistically Enhances Hypomethylating Therapy through Targeting of PLK1 in Acute Myeloid Leukemia.
AU  - Nawrocki ST
AU  - Wang N
AU  - Espitia CM
AU  - Wu H
AU  - Villa Celi C
AU  - Olea J
AU  - Zarand P
AU  - Dadrastoussi H
AU  - Matta H
AU  - Sureshkumar S
AU  - Gamble ME
AU  - Hakim NL
AU  - Drum D
AU  - Angeles J
AU  - Wu K
AU  - Zhong JF
AU  - Chen X
AU  - Duong A
AU  - Carew JS
AU  - Kelly KR
PY  - 2026
JO  - Cancer research communications
DO  - 10.1158/2767-9764.crc-26-0035
UR  - https://doi.org/10.1158/2767-9764.crc-26-0035
ER  - 

APA

ST, N., N, W., CM, E., H, W., C, V. C., J, O., P, Z., H, D., H, M., S, S., ME, G., NL, H., D, D., J, A., K, W., JF, Z., X, C., A, D., JS, C., & KR, K. (2026). p97 Inhibition Synergistically Enhances Hypomethylating Therapy through Targeting of PLK1 in Acute Myeloid Leukemia.. Cancer research communications. https://doi.org/10.1158/2767-9764.crc-26-0035

Source records